Fidelity bids adieu to medical imaging

Article

Call it a sad commentary on the state of the medical imaging market: Fidelity Medical hasexited the industry in favor of greener pastures in retail stationery.The Florham Park, NJ, company this month announced that it hassold its x-ray digitization

Call it a sad commentary on the state of the medical imaging market: Fidelity Medical hasexited the industry in favor of greener pastures in retail stationery.The Florham Park, NJ, company this month announced that it hassold its x-ray digitization business to Chester Holdings Ltd.in a transaction valued at $900,000.

Fidelity has had a rough time in the industry since 1992, whenthen-CEO Efraim Landa left the firm after revealing that the company'sbalance sheet had been inflated (SCAN 8/26/92).

Fidelity hired former Siemens executive Werner Haas in an effortto turn the company around. Red ink continued to flow from thefirm, however, and a shareholder lawsuit related to the bogusfinancial results dogged the company. Fidelity posted a net lossof $5 million in 1992, a net loss of $10.1 million in 1993 anda net loss of $1.9 million last year. Fidelity postponed the filingof its 1994 results for several months due to doubts about thecompany's future (SCAN 3/1/95 and 2/1/95).

Fidelity began divesting its businesses in 1993, when it soldan unprofitable Israeli subsidiary. It shifted its focus awayfrom medical imaging when it bought U.K. stationery retailer CornicheDistribution last month (SCAN 4/12/95).

Fidelity completed its exit from radiology this month whenit sold all of its stock in medical imaging products in exchangefor 2.2 million shares of Fidelity common stock acquired by Chesterin connection with the Corniche acquisition. Fidelity also receiveda 180-day promissory note for $200,000.

Fidelity's new chairman, Brian Baylis, said the company madethe move to exit a business where it had been generating yearsof losses.

"Fidelity's board of directors believes that Fidelity'sfuture lies outside (medical imaging)," Baylis said. "Thedisposition of the medical imaging products business will allowFidelity to focus its attention and resources on the developmentand expansion of its stationery operations."

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.